98%
921
2 minutes
20
Objective: To examine the likelihood of head acceleration events (HAEs) as a function of previously identified risk factors: match time, player status (starter or substitute) and pitch location in elite-level men's and women's rugby union matches.
Methods: Instrumented mouthguard data were collected from 179 and 107 players in the men's and women's games and synchronised to video-coded match footage. Head peak resultant linear acceleration (PLA) and peak resultant angular acceleration were extracted from each HAE. Field location was determined for HAEs linked to a tackle, carry or ruck. HAE incidence was calculated per player hour across PLA recording thresholds with 95% CIs estimated. Propensity was calculated as the percentage of contact events that caused HAEs across PLA recording thresholds, with a 95% CI estimated. Significance was assessed by non-overlapping 95% CIs.
Results: 29 099 and 6277 HAEs were collected from 1214 and 577 player-matches in the men's and women's games. No significant differences in match quarter HAE incidence or propensity were found. Substitutes had higher HAE incidence than starters at lower PLA recording thresholds for men but similar HAE propensity. HAEs were more likely to occur in field locations with high contact event occurrence.
Conclusion: Strategies to reduce HAE incidence need not consider match time or status as a substitute or starter as HAE rates are similar throughout matches, without differences in propensity between starters and substitutes. HAE incidence is proportional to contact frequency, and strategies that reduce either frequency or propensity for contact to cause head contact may be explored.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11459297 | PMC |
http://dx.doi.org/10.1136/bmjsem-2024-001954 | DOI Listing |
J Allergy Clin Immunol Pract
August 2025
Institute of Allergology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universitätsmedizin Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany. Electronic a
Background: Poor compliance with hereditary angioedema guidelines for on-demand treatment is common due to challenges with parenteral administration. Sebetralstat, an oral plasma kallikrein inhibitor, demonstrated faster times to beginning of symptom relief, reduction in attack severity, and complete resolution than placebo in the phase 3 KONFIDENT trial (NCT05259917).
Objective: This analysis evaluated long-term safety and effectiveness of sebetralstat in KONFIDENT-S (NCT05505916), an ongoing, 2-year, open-label extension study.
J Infect Public Health
July 2025
Department of Population Health, New York University Grossman School of Medicine, New York, NY, United States.
Background: Communities hardest-hit by early SARS-CoV-2 outbreaks accrued more immunity, but prioritizing these communities for vaccination could reduce health disparities. Optimal vaccine allocation depends on inequality aversion, i.e.
View Article and Find Full Text PDFSports Med
August 2025
Centre for Health and Injury and Illness Prevention in Sport, University of Bath, Bath, UK.
Objectives: The aim of this study was to describe the incidence and magnitude of head acceleration events (HAEs) during elite men's and women's rugby union training for different contact training levels and drill types.
Method: Data were collected during the 2022-23 and 2023-24 seasons from 203 men and 125 women from 13 clubs using instrumented mouthguards (iMGs) during in-season training. One author reviewed the training videos to identify the contact level and drill type.
BMJ Open
July 2025
New York University Grossman School of Medicine, New York City, New York, USA.
Objectives: To compare the impact of different HIV self-testing (HIVST) distribution modalities on population-level HIV outcomes.
Design: Mathematical modelling study.
Setting: Six counties in western Kenya.
Eur Radiol
July 2025
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Objective: Since non-enhanced pelvic MRI is routinely performed for staging rectal cancer, an additional scan of the liver during pelvic MRI could be easily acquired. This study aimed to evaluate the potential utility of routinely adding non-enhanced abbreviated MRI (NE-AMRI) for liver metastasis screening, in comparison to CT alone (the current guideline-recommended modality), and CT combined with AMRI using hepatobiliary phase imaging (HBP-AMRI) (another potential alternative).
Materials And Methods: This retrospective study included patients diagnosed with rectal cancer between 2017 and 2022 at a tertiary institution.